Search results for "brain injuries"

showing 10 items of 139 documents

Brain-derived neurotrophic factor (Val66Met) polymorphism does not influence recovery from a post-traumatic vegetative state: a blinded retrospective…

2012

Brain-derived neurotrophic factor (BDNF) is a neurotrophin that influences neuronal plasticity throughout life. Emergence from a vegetative state (VS) after a traumatic brain injury (TBI) implies that the brain undergoes plastic changes. A common polymorphism in the BDNF gene—BDNF Val66Met (referred to herein as BDNFMet)—impairs cognitive function in healthy subjects. The aim of this study was to determine whether the BDNFMet polymorphism plays a role in the recovery of consciousness and cognitive functions in patients in a VS after a TBI. Fifty-three patients in a VS 1 month after a TBI were included in the study and genotyped for the BDNFMet polymorphism. Scores of levels of cognitive fun…

OncologyAdultMalemedicine.medical_specialtydisorders of consciousneAdolescentGenotypeTraumatic brain injuryPolymorphism Single Nucleotidevegetative stateYoung AdultNeurotrophic factorsInternal medicineNeuroplasticitymedicineHumansYoung adultPsychiatryRetrospective StudiesBrain-derived neurotrophic factorbiologytraumatic brain injuryBrain-Derived Neurotrophic FactorPersistent Vegetative Statelevels of cognitive functioninggenetic factorRetrospective cohort studyCognitionRecovery of FunctionMiddle Agedmedicine.diseasenervous systemBrain Injuriesbiology.proteinFemaleNeurology (clinical)PsychologyPolymorphism Restriction Fragment LengthNeurotrophinJournal of neurotrauma
researchProduct

Auditory and Cognitive Deficits Associated with Acquired Amusia after Stroke: A Magnetoencephalography and Neuropsychological Follow-Up Study

2010

Acquired amusia is a common disorder after damage to the middle cerebral artery (MCA) territory. However, its neurocognitive mechanisms, especially the relative contribution of perceptual and cognitive factors, are still unclear. We studied cognitive and auditory processing in the amusic brain by performing neuropsychological testing as well as magnetoencephalography (MEG) measurements of frequency and duration discrimination using magnetic mismatch negativity (MMNm) recordings. Fifty-three patients with a left (n = 24) or right (n = 29) hemisphere MCA stroke (MRI verified) were investigated 1 week, 3 months, and 6 months after the stroke. Amusia was evaluated using the Montreal Battery of …

PITCHMalemagnetoencephalographyMiddle Cerebral ArteryAnatomy and Physiologylcsh:MedicineMismatch negativity312 Clinical medicineNeuropsychological TestsAudiologymagnetic fieldsCardiovascularSocial and Behavioral SciencesBehavioral NeuroscienceLearning and MemoryCognition0302 clinical medicinePsychologyMedicinelcsh:Sciencemagnetoencephalography and neuropsychologicalClinical NeurophysiologyMultidisciplinarymedicine.diagnostic_testBRAIN RESPONSES05 social sciencesStroke RehabilitationCognitive flexibilityNeuropsychologyMagnetoencephalographyElectroencephalographyExperimental Psychologyfollow-up studyMiddle Aged3. Good healthElectrophysiologyStrokeHemorrhagic StrokeClinical PsychologyMemory Short-TermNeurologyMedicineSensory PerceptionFemaleMUSIC PERCEPTION DEFICITSResearch ArticleAdultCORTEXmedicine.medical_specialtyMISMATCH NEGATIVITY MMN515 PsychologyCognitive NeuroscienceCerebrovascular DiseasesNeuroimagingAmusiaAuditory cortex050105 experimental psychologyLateralization of brain functionPerceptual Disorders03 medical and health sciencesNeuropsychologyDiagnostic MedicineSPEECH INTONATIONHumans0501 psychology and cognitive sciencesBiologyMusic TherapyIschemic StrokeAuditory CortexCONGENITAL AMUSIAbusiness.industryMEMORYlcsh:R3112 NeurosciencesMagnetoencephalographymedicine.diseaseAuditory and cognitive deficits6131 Theatre dance music other performing artsNeuroanatomyDISCRIMINATIONBrain Injurieslcsh:QNEURAL-NETWORKSbusinessNeurocognitive030217 neurology & neurosurgeryNeuroscienceFollow-Up Studies
researchProduct

The Blood–Brain Barrier as a Target in Traumatic Brain Injury Treatment

2014

Traumatic brain injury (TBI) is one of the most frequent causes of death in the young population. Several clinical trials have unsuccessfully focused on direct neuroprotective therapies. Recently immunotherapeutic strategies shifted into focus of translational research in acute CNS diseases. Cross-talk between activated microglia and blood–brain barrier (BBB) could initiate opening of the BBB and subsequent recruitment of systemic immune cells and mediators into the brain. Stabilization of the BBB after TBI could be a promising strategy to limit neuronal inflammation, secondary brain damage and acute neurodegeneration. This review provides an overview on the pathophysiology of TBI and brain…

Pathologymedicine.medical_specialtyTraumatic brain injuryPeroxisome Proliferator-Activated ReceptorsBrain EdemaInflammationBrain damageBlood–brain barrierNeuroprotectionRosiglitazoneReceptors GlucocorticoidmedicineHumansHypoglycemic AgentsMyosin-Light-Chain KinaseNeuroinflammationInflammationPioglitazoneMicrogliabusiness.industryNeurodegenerationNeurodegenerative DiseasesGeneral Medicinemedicine.diseaseCell HypoxiaNeuroprotective Agentsmedicine.anatomical_structurenervous systemBlood-Brain BarrierBrain InjuriesThiazolidinedionesmedicine.symptombusinessNeuroscienceArchives of Medical Research
researchProduct

A Decision-Tree Approach to Assist in Forecasting the Outcomes of the Neonatal Brain Injury

2021

Neonatal brain injury or neonatal encephalopathy (NE) is a significant morbidity and mortality factor in preterm and full-term newborns. NE has an incidence in the range of 2.5 to 3.5 per 1000 live births carrying a considerable burden for neurological outcomes such as epilepsy, cerebral palsy, cognitive impairments, and hydrocephaly. Many scoring systems based on different risk factor combinations in regression models have been proposed to predict abnormal outcomes. Birthweight, gestational age, Apgar scores, pH, ultrasound and MRI biomarkers, seizures onset, EEG pattern, and seizure duration were the most referred predictors in the literature. Our study proposes a decision-tree approach b…

Pediatricsmedicine.medical_specialtyHealth Toxicology and MutagenesisEncephalopathyArticleCerebral palsy03 medical and health sciencesEpilepsy0302 clinical medicinePregnancySeizuresMedicinerisk factorsHumans030212 general & internal medicineRisk factorRetrospective StudiesEpilepsyneonatal brain injuryneurodevelopmentbusiness.industryNeonatal encephalopathyRPublic Health Environmental and Occupational Healthabnormal outcomesInfant NewbornGestational ageInfantElectroencephalographyOdds ratiomedicine.diseasedecision-tree algorithmsBrain InjuriesApgar ScoreMedicineApgar scoreFemalebusiness030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Systemic PaO2 oscillations cause mild brain injury in a pig model

2016

OBJECTIVE: Systemic PaO2 oscillations occur during cyclic recruitment and derecruitment of atelectasis in acute respiratory failure and might harm brain tissue integrity. DESIGN: Controlled animal study. SETTING: University research laboratory. SUBJECTS: Adult anesthetized pigs. INTERVENTIONS: Pigs were randomized to a control group (anesthesia and extracorporeal circulation for 20 hr with constant PaO2, n = 10) or an oscillation group (anesthesia and extracorporeal circulation for 20 hr with artificial PaO2 oscillations [3 cycles min⁻¹], n = 10). Five additional animals served as native group (n = 5). MEASUREMENTS AND MAIN RESULTS: Outcome following exposure to artificial PaO2 oscillations…

Pulmonary Atelectasismedicine.medical_specialtySwinemedicine.medical_treatment10208 Institute of NeuropathologyHippocampusInflammation610 Medicine & healthHippocampal formationReal-Time Polymerase Chain ReactionCritical Care and Intensive Care Medicinegamma-Aminobutyric acidRNA ComplementaryRandom Allocation03 medical and health sciencesExtracorporeal Membrane Oxygenation0302 clinical medicine030202 anesthesiologyNeurotransmitter receptorInternal medicinemedicineExtracorporeal membrane oxygenationAnimalsReceptoralpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acidgamma-Aminobutyric AcidRespiratory Distress Syndromebusiness.industryExtracorporeal circulationRespiration Artificialrespiratory tract diseasesEndocrinologyBrain Injuries570 Life sciences; biologyBlood Gas AnalysisInflammation Mediatorsmedicine.symptombusiness2706 Critical Care and Intensive Care Medicine030217 neurology & neurosurgerymedicine.drug
researchProduct

Reply to Chousterman et al.: Delaying Renal Replacement Therapy Could Be Harmful in Patients with Acute Brain Injury

2019

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCritical IllnessAcute kidney injuryMEDLINEAcute Kidney InjuryCritical Care and Intensive Care Medicinemedicine.diseaseRenal Replacement TherapyText miningBrain InjuriesCritical illnessCorrespondencemedicineHumansIn patientRenal replacement therapyIntensive care medicinebusinessAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

Therapeutic Approaches for Cerebrovascular Dysfunction After Aneurysmal Subarachnoid Hemorrhage: An Update and Future Perspectives

2022

Aneurysmal subarachnoid hemorrhage (aSAH) is a severe subtype of stroke occurring at a relatively young age with a significant socioeconomic impact. Treatment of aSAH includes early aneurysm exclusion, intensive care management, and prevention of complications. Once the aneurysm rupture occurs, blood spreading within the subarachnoid space triggers several molecular pathways causing early brain injury and delayed cerebral ischemia. Pathophysiologic mechanisms underlying brain injury after aSAH are not entirely characterized, reflecting the difficulties in identifying effective therapeutic targets for patients with aSAH. Although the improvements of the last decades in perioperative manageme…

Quality of lifeCerebral InfarctionVasospasmNeuroprotectionBrain IschemiaClinical trialBrain InjuriesHumansVasospasm IntracranialNimodipineSubarachnoid hemorrhageSurgeryNeurology (clinical)Combination therapyWorld Neurosurgery
researchProduct

Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

2014

Antonino Tuttolomondo, Rosaria Pecoraro, Antonio Pinto Biomedical Department of Internal and Specialistic Medicine, University of Palermo, Palermo, Italy Abstract: The brain is very actively involved in immune-inflammatory processes, and the response to several trigger factors such as trauma, hemorrhage, or ischemia causes the release of active inflammatory substances such as cytokines, which are the basis of second-level damage. During brain ischemia and after brain trauma, the intrinsic inflammatory mechanisms of the brain, as well as those of the blood, are mediated by leukocytes that communicate with each other through cytokines. A neuroinflammatory cascade has been reported to be activ…

Settore MED/09 - Medicina InternaTraumatic brain injurytumor necrosis factor inhibitorsCentral nervous systemIschemiaPharmaceutical ScienceReviewAMPA receptorEtanerceptBrain ischemiaTBIDrug DiscoverymedicineAnimalsHumansStroke trauma TNF-alfa antagonistPharmacologyMicrogliaTumor Necrosis Factor-alphabusiness.industrytraumatic brain injurylcsh:RM1-950Anti-Inflammatory Agents Non-Steroidalbrain injurymedicine.diseaseStrokelcsh:Therapeutics. Pharmacologymedicine.anatomical_structureBrain InjuriesImmunologyTumor necrosis factor alphabusinessmedicine.drugDrug Design, Development and Therapy
researchProduct

Neuroprotective properties of xenon and helium in an in vitro model of traumatic brain injury: one small step or one big jump?

2008

Settore MED/27 - Neurochirurgiabusiness.industryTraumatic brain injurychemistry.chemical_elementCritical Care and Intensive Care Medicinemedicine.diseaseNeuroprotectionXenum helium neuroprotectionIn vitro modelXenonchemistryAnesthesiaJumpMedicinebusinessAnesthetics; Inhalation; administration /&/ dosage/therapeutic use Animals Brain Injuries; prevention /&/ control Disease Models; Animal Helium; administration /&/ dosage/therapeutic use Mice Mice; Inbred C57BL Tissue Culture Techniques Xenon; administration /&/ dosage/therapeutic use
researchProduct

Update on mechanism and therapeutic implications of spinal cord stimulation and cerebral hemodynamics: A narrative review

2017

Spinal cord stimulation (SCS) is well known for its early role in the management of chronic pain, mainly failed back surgery syndrome (FBSS), spasticity, and bowel and bladder dysfunction. In more recent years, SCS has been proposed for patients suffering from refractory angina or peripheral vasculopathies in order to gain symptom relief, thus indicating some hemodynamic effect on the peripheral circulation. Taking into account this scientific observation, since the late1980s, researchers have started to investigate the potential effect of SCS on cerebral blood flow (CBF) regulation and its possible application in certain pathological settings dealing with vascular pattern dysfunction, such…

Subarachnoid hemorrhage030204 cardiovascular system & hematologyCerebral autoregulationBrain IschemiaBrain ischemia03 medical and health sciences0302 clinical medicineAnimalsHomeostasisHumansVasospasm IntracranialMedicineSpasticitySympathectomyBrain injuryStrokeBrain Neoplasmsbusiness.industrySettore MED/27 - NeurochirurgiaBrain injury; Cerebral autoregulation; Cerebral blood flow; Functional sympathectomy; Spinal cord stimulation; Stroke; Vasospasm; Surgery; Neurology (clinical)HemodynamicsChronic painVasospasmFunctional sympathectomySubarachnoid HemorrhageCerebral blood flowmedicine.diseaseVasospasmCerebral autoregulationStrokenervous systemCerebral blood flowSpinal cord stimulationBrain InjuriesCerebrovascular CirculationAnesthesiaSurgeryNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgery
researchProduct